± HEALTH Objective To evaluate the accuracy, completeness, clarity, source transparency, and readability of leading AI…+ HEALTH Background Early prediction of in-hospital mortality in critically ill patients can aid clinicians in optimiz…+ HEALTH Hypertension is a major risk factor for cardiovascular diseases, with changes in gut microbiota composition a…+ SCIENCE Fire ants (Solenopsis spp. Westwood) pose a major ecological and economic threat, mainly due to the invasive…± HEALTH Objectives The current study aimed to quantify the diagnostic accuracy of commonly utilized chatbots includin…+ HEALTH Objective Despite elevated risk for epilepsy following traumatic brain injury (TBI), there are limited tools…± HEALTH Timely and accurate diagnosis of ST-elevation myocardial infarction (STEMI) is critical in military operation…+ HEALTH Colorectal cancer (CRC) exhibits substantial metabolic heterogeneity. This study developed a robust prognosti…
TruaceTracing the truth around AIWednesday, August 5, 2026
Subscribe
TRV-2026-0617Certified recordPeer-reviewed

[Artificial intelligence in hypertension: where do we stand?]

Artificial intelligence (AI) is entering the study of hypertension, serving both primarily clinical purposes - to assist practicing physicians - and research objectives. Hypertension presents certain specific characteristics that should be carefully considered when using AI. The measured value of blood pressure is an extremely variable parameter that is difficult to standardize and measure with precision. At present, AI is able to provide very simple, clear, and well-documented answers to clinical questions rega…

Health · The Trace — both readings · certified 2026-08-01 · v1 · article view · machine-readable

Current reading — gain

AI systems can provide simple, clear, well-documented answers to clinical questions about managing patients with hypertension to assist practicing physicians.

Current reading — problem

There are few controlled clinical trials that directly compare AI tools to traditional medical literature and clinical experience for hypertension on key endpoints of real clinical value to prove superiority.

What this doesn’t fix

Evidence base is limited by few controlled trials directly comparing AI to traditional clinical practice on clinically meaningful endpoints, and by measurement variability of blood pressure.

Evidence

Reader signal

How should this claim be treated?

Cite this record

Truvace Impact Record TRV-2026-0617, v1: “[Artificial intelligence in hypertension: where do we stand?].” Truvace, 2026-08-01. /record/TRV-2026-0617 (accessed at citation time). sha256 78b56ede7d254b55…

Calibration history

Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.

  1. Certifiedv178b56ede7d25…

    Certified into the record

Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-0617 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.